Novartis

LEQVIO

Manufacturer:

Novartis

Leqvio HCPCS:

J1306

HCPCS Code Descriptor:

Injection, inclisiran, 1 mg

Category:

J Code

Leqvio NDCs:

00078-1000-60

Primary Type:

Cardiology

Generic/Specialty Status:

Single-Source

Route of Administration:

Subcutaneous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Leqvio:

LEQVIO is a Cardiology drug manufactured by Novartis and administered via the Subcutaneous route of administration. The J Code: J1306 is aligned to the drug LEQVIO.

ACCESS PRICING AND MORE BY REGISTERING

J1306 Added Date:

July 1, 2022

J1306 Effective Date:

July 1, 2022

J1306 Termination Date:

HCPCS Active

Leqvio billing and coding information can be found through Novartis at the link below:
Leqvio patient assistance information can be found through Novartis Patient Support at the URL: https://www.novartis.us/our-products/patient-assistance/patient-assistance-foundation-enrollment
LEQVIO prescribing information can be found at the link below:
Information regarding LEQVIO’s side effects can be found at MedlinePlus